Please login to the form below

Not currently logged in

Nycomed strengthen CEE presence

Swiss company buys 20 branded generics from sanofi-aventis and Zentiva

Nycomed has agreed to buy 20 branded generic products from sanofi-aventis and Zentiva in an attempt to strengthen its market position in Central and Eastern Europe, in particular in the Czech Republic and Slovakia.

Under the terms of the deal, Nycomed will acquire a portfolio of branded generic drugs in the Czech Republic, Slovakia, Romania, Hungary, Estonia and Bulgaria, with an annual turnover of around €17m. In addition, Nycomed will also assume future production.

As part of the deal, Nycomed has purchased Zentiva's well-established hypnotic hypnogen (zolipidem) in the Czech Republic, Slovak Republic and Estonia.

Most of the purchased products are in the Czech Republic and include a strong franchise of beta-blockers (Vasocardin, Betaxa and Tenoloc), which will bolster the company's cardiovascular business around Ebrantil. Other brands include Trental, Flavobion and Ercefuryl.

"These brands will complement our local portfolios very well," said Frank Rotmann, area manager Central and Eastern Europe, Nycomed.

The purchase will be completed as an asset transfer transaction – no further financial details of the deal were available. The European Commission and the Czech Antimonopoly Office have approved the deal, which is expected to close in September 2009. 

3rd August 2009


Featured jobs

Subscribe to our email news alerts


Add my company
Cello Health

Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...

Latest intelligence

How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...
Medopad: the up and coming unicorn transforming remote patient monitoring
Blue Latitude Health speaks to Medopad’s Martha Carruthers to learn how the start-up’s modular apps are helping patients with complex diseases....